Article Details
Retrieved on: 2020-11-23 13:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The European Commission (EC) has approved a <b>Pfizer</b> biosimilar for pegfilgrastim (Nyvepria), paving the way for marketing to begin. The drug is ...
Article found on: www.centerforbiosimilars.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here